Goldman Sachs Group Inc Annexon, Inc. Transaction History

Goldman Sachs Group Inc

$706 Billion
Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,630,649 shares of ANNX stock, worth $5.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,630,649

Previous 841,582 93.76%

Holding current value

$5.14 Million

Previous $1.62 Million 140.95%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.38 - $2.73 $1.09 Million - $2.15 Million	789,067 Added 93.76%	1,630,649 $3.91 Million
Q1 2025 May 09, 2025	SELL	$1.93 - $5.5 $917,577 - $2.61 Million	-475,429 Reduced 36.1%	841,582 $1.62 Million
Q4 2024 Feb 11, 2025	SELL	$4.44 - $7.63 $2.61 Million - $4.48 Million	-587,367 Reduced 30.84%	1,317,011 $6.76 Million
Q3 2024 Nov 14, 2024	BUY	$4.49 - $7.2 $5.87 Million - $9.42 Million	1,308,187 Added 219.42%	1,904,378 $11.3 Million
Q2 2024 Aug 13, 2024	BUY	$4.33 - $6.79 $143,864 - $225,597	33,225 Added 5.9%	596,191 $2.92 Million
Q1 2024 May 15, 2024	BUY	$4.03 - $7.81 $1.12 Million - $2.17 Million	278,033 Added 97.58%	562,966 $4.04 Million
Q4 2023 Feb 13, 2024	BUY	$1.63 - $4.63 $64,018 - $181,843	39,275 Added 15.99%	284,933 $1.29 Million
Q3 2023 May 14, 2024	SELL	$2.13 - $3.84 $83,655 - $150,816	-39,275 Reduced 13.78%	245,658 $579,000
Q3 2023 Nov 14, 2023	BUY	$2.13 - $3.84 $337,076 - $607,687	158,252 Added 181.05%	245,658 $579,000
Q2 2023 May 14, 2024	SELL	$2.1 - $6.37 $522,291 - $1.58 Million	-248,710 Reduced 74.0%	87,406 $307,000
Q2 2023 Aug 14, 2023	SELL	$2.1 - $6.37 $522,291 - $1.58 Million	-248,710 Reduced 74.0%	87,406 $307,000
Q1 2023 May 14, 2024	BUY	$3.74 - $7.46 $1.06 Million - $2.11 Million	282,238 Added 523.85%	336,116 $1.29 Million
Q1 2023 May 11, 2023	BUY	$3.74 - $7.46 $1.06 Million - $2.11 Million	282,238 Added 523.85%	336,116 $1.29 Million
Q4 2022 May 14, 2024	SELL	$4.56 - $6.61 $71,578 - $103,757	-15,697 Reduced 22.56%	53,878 $278,000
Q4 2022 Feb 13, 2023	SELL	$4.56 - $6.61 $71,578 - $103,757	-15,697 Reduced 22.56%	53,878 $278,000
Q3 2022 May 14, 2024	SELL	$3.75 - $6.63 $29,662 - $52,443	-7,910 Reduced 10.21%	69,575 $430,000
Q3 2022 Nov 10, 2022	SELL	$3.75 - $6.63 $29,662 - $52,443	-7,910 Reduced 10.21%	69,575 $0
Q2 2022 May 14, 2024	SELL	$2.11 - $4.06 $437,715 - $842,238	-207,448 Reduced 72.81%	77,485 $292,000
Q2 2022 Aug 15, 2022	SELL	$2.11 - $4.06 $528,588 - $1.02 Million	-250,516 Reduced 76.38%	77,485 $292,000
Q1 2022 May 16, 2022	BUY	$2.73 - $11.94 $451,367 - $1.97 Million	165,336 Added 101.64%	328,001 $896,000
Q4 2021 Feb 14, 2022	BUY	$11.49 - $22.0 $1.5 Million - $2.88 Million	130,891 Added 411.94%	162,665 $1.87 Million
Q3 2021 Nov 10, 2021	BUY	$16.35 - $23.4 $519,504 - $743,511	31,774 New	31,774 $591,000

Others Institutions Holding ANNX

# of Institutions

138

Shares Held

96.4M

Call Options Held

Put Options Held

63.4K

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $150M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Annexon, Inc. Transaction History